Martin Gleave

Researcher

Related Research

Related News & Events

Press Release|May 27, 2020

Clinical trial reveals more effective way to treat aggressive prostate cancers

A clinical trial led by BC-based researchers partly funded by the TFRI has revealed that administering abiraterone acetate first, with enzalutamide af...

Research Highlight|October 16, 2019

New finding sheds light on neuroendocrine prostate cancer progression

New study reveals how RNA splicing of BHC80 promotes the development of treatment-induced neuroendocrine prostate cancer, providing potential avenue f...

Research Highlight|June 03, 2019

New research suggests immunotherapy could help nearly 50 per cent of patients with rare mesothelioma

A team of scientists partly funded by the Terry Fox Research Institute has shown that nearly half of all patients with peritoneal mesothelioma (PeM), ...

Research Highlight|May 15, 2018

Breakthrough test uses ctDNA to determine treatment resistance in advanced prostate cancer patients

Metastatic castration-resistant prostate cancer (mCRPC) patients are now one step closer to more personalized treatment, thanks to a new test that can...

Research Highlight|January 03, 2017

Clusterin knockdown sensitizes prostate cancer cells to therapies by modulating mitosis

A study by a TFRI-funded team based at the Vancouver Prostate Centre has found that silencing a key driver of castrate-resistant prostate cancer and r...

Press Release|September 07, 2016

TFRI ANNOUNCES 2016 FUNDING COMPETITION AWARD RECIPIENTS

Vancouver, BC – Six outstanding Canadian research teams will use $27.3 million in new funding to engineer precision medicines for patients whose cance...

TFRI News|July 25, 2012

New pan-Canadian Terry Fox Research Institute network receives close to $4-million to find better tools to treat prostate cancer

All News & Events

Martin Gleave

Funding Opportunities

Our Research

Impact

About Cancer

Updates

About Us

Contact